相关实验视频
Updated: Jan 7, 2026
02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
5.8K
锡卡明TM:在抗炎药物领域的新参与者
Charles Lynde1,2, Louis Flamand3, Vincent McCarty4
1Department of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.
Biomedicines
|December 30, 2025
概括
提卡明TM是一种新型植物化合物,与领先的皮质类固醇和非类固醇药物相比,它在体外抑制了关键的炎症化学因子. 这表明了蒂卡明TM.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 慢性炎症和自身免疫性疾病涉及持续的细胞因子/化学因子驱动的炎症.
- 目前的疗法有局限性,包括不良影响.
- 锡卡明TM是一种新型植物药物,具有已证明的抗炎作用和安全性.
研究的目的:
- 为了比较ThykamineTM与已知抗炎药物的体外化学激素抑制功效.
- 评估ThycaminTM在抑制关键的促炎化学基因方面的疗效.
主要方法:
- 在实验室中比较ThykamineTM与皮质类固醇 (贝他美沙,克洛贝塔索尔,水皮质,普雷德尼松) 和非类固醇药物 (克里萨博罗尔,皮梅克罗利木斯).
- 在脂多糖糖刺激的U937细胞中测试化学抑制 (MCP-1,MIP-1α,MIP-1β,RANTES) 的评估.
- 用于强度确定的曲线下面积 (AUC) 分析.
主要成果:
- 与所有测试剂相比,蒂卡明TM在抑制MCP-1,MIP-1α和MIP-1β方面表现出显著更大的功效.
- 锡卡明TM抑制了RANTES分泌,与普得尼松相比,比大多数其他药物更有效,除了高度的克里萨博罗尔外.
- 蒂卡明TM显示出强大的抑制作用,没有细胞毒性,特别是在较低度时.
结论:
- 锡卡明TM在体外表现出优越或可比的化学激素抑制功效,与已知抗炎药物相比.
- 它的多目标作用和有利的安全性概况表明,它对化基因介导炎症具有潜在的临床优势.
- 对于自身免疫性疾病,需要进一步进行临床评估.
相关概念视频
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
846
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
846
01:28Depolarizing Blockers: Mechanism of Action
2.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.6K
01:26Cholinergic Antagonists: Therapeutic Uses
1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
475
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
475
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
516
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
516
01:24Cholinergic Antagonists: Pharmacokinetics
872
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
872